| ||||||||||||||
|
|
|||||||||||||
Departments of Anesthesia and Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Abstract
Certain patients with dermatomyositis show a profound peripheral weakness. In some, this weakness is improved with the administration of anticholinesterase drugs. In 1958, Churchill-Davidson and Richardson investigated ten patients with dermatomyositis (1). They found evidence of a myasthenic response (using decamethonium) in two: in one of these patients a bronchogenic neoplasm was present. These authors caution, therefore, that muscle relaxants be used carefully when anesthetizing patients with dermatomyositis. The present report describes a case of prolonged neuromuscular blockade with the shortacting, nondepolarizing relaxant vecuronium in a patient with polymyositis who subsequently displayed no abnormality of neuromuscular transmission on electromyographic testing.
|